Campbell & CO Investment Adviser LLC Edwards Lifesciences Corp Transaction History

Campbell & CO Investment Adviser LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	SELL	$69.28 - $93.38 $28,751 - $38,752	-415 Reduced 10.78%	3,434 $237,000
Q2 2023 Aug 11, 2023	BUY	$81.41 - $94.33 $313,347 - $363,076	3,849 New	3,849 $363,000
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $218,901 - $280,245	3,205 New	3,205 $239,000
Q2 2019 Jul 10, 2019	SELL	$55.74 - $64.41 $159,583 - $184,405	-2,863 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$47.89 - $64.05 $137,109 - $183,375	2,863 New	2,863 $548,000
Q4 2017 Feb 14, 2018	SELL	$33.79 - $39.39 $341,177 - $397,720	-10,097 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$36.29 - $38.83 $366,420 - $392,066	10,097	10,097 $1.1 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.